20
Derivados Quimicos Sau, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MILNACIPRAN HYDROCHLORIDE, with a corresponding US DMF Number 26611.
Remarkably, this DMF maintains an Active status since its submission on November 07, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 31, 2013, and payment made on November 07, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II